Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
JAMA Dermatology · 2026
DOI: 10.1001/jamadermatol.2025.4652 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, 2026. Verfasst von Amit Garg und 48 weiteren Autor:innen. Beteiligte Einrichtung: Northwell, New Hyde Park, New York. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Clinical Trials as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Importance Accurate classification and reliability in assessment for lesions of hidradenitis suppurativa (HS) by investigators is critical to the determination of responder status and to overall data quality in clinical trials.
Objective
To establish consensus-based morphological definitions of HS lesions and guidance statements that standardize investigator lesion assessments for implementation in clinical trials. Evidence Review Health professionals (primarily dermatologists) with expertise in the measurement of HS disease activity as well as novice raters completed a preliminary questionnaire in which participants were asked to assess images of HS lesions and provide qualitative feedback on their decision making. Based on this feedback, detailed morphologic definitions for lesions and guidance statements that standardize lesion assessments were formulated and presented for consensus voting in 2 electronic Delphi surveys. A virtual group discussion after round 1 supported participants in round 2 voting.
Findings
Response rates were 84.7% (50 of 59), 86.0% (43 of 50), and 90.9% (40 of 44) in the preliminary, electronic Delphi round 1, and electronic Delphi round 2 surveys, respectively. Morphological definitions for 11 lesion types achieved the prespecified 70% consensus threshold, with 9 definitions reaching at least 90% agreement. After 2 electronic Delphi rounds, 16 of 18 guidance statements achieved the prespecified consensus threshold, with 13 statements receiving endorsement from more than 80% of participants. Two guidance statements related to assessment of tunneled plaques with multiple openings and assessment of scalp lesions failed to reach consensus. Conclusions and Relevance Common morphologic definitions and guidance that standardize assessment of HS lesions can be implemented in clinical trial protocols and investigator trainings with the goals of improving accuracy and reliability of investigator ratings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Northwell, New Hyde Park, New York.
- Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
- Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
- Department of Dermatology, University Hospital of the RWTH Aachen University, Aachen, Germany.
- O.U. Dermatology, Azienda Ospedaliera, University of Ferrara, Ferrara, Italy.
Zitieren
APA
Garg, A., Strunk, A., Midgette, B., Frasier, K., Cohn, E., Aarts, P., Alavi, A., Alhusayen, R., Bechara, B. F. G., Bettoli, V., Brassard, A., Brown, D. P., Chandran, N. S., Choon, S. E., Cohen, S. R., Daveluy, S., Del Marmol, V., Dellavalle, R. P., Emtestam, L., …, & Ingram, J. R. (2026). Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2025.4652
Vancouver
Garg A, Strunk A, Midgette B, Frasier K, Cohn E, Aarts P, et al. Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa. JAMA Dermatology. 2026. doi:10.1001/jamadermatol.2025.4652
BibTeX
@article{Garg2026,
author = {Garg, Amit and Strunk, Andrew and Midgette, Bria and Frasier, Kelly and Cohn, Erica and Aarts, Pim and Alavi, Afsaneh and Alhusayen, Raed and Bechara, Bitte Falk G and Bettoli, Vincenzo and Brassard, Alain and Brown, Debra P and Chandran, Nisha Suyien and Choon, Siew Eng and Cohen, Steven R and Daveluy, Steven and Del Marmol, Veronique and Dellavalle, Robert P and Emtestam, Lennart and Farida, Benhadou and Fernandez-Penas, Pablo and Flowers, R Hal and Frew, John W and Gebauer, Kurt A and Giamarellos-Bourboulis, Evangelos J and Goldfarb, Noah and Horváth, Barbara and Hsiao, Jennifer L and Jemec, Gregor and Lowes, Michelle A and Marzano, Angelo V and Matusiak, Lukasz and Micheletti, Robert G and Oon, Hazel H and Orenstein, Lauren A V and Ortega-Loayza, Alex G and Paek, So Yeon and Pascual, Jose C and Piguet, Vincent and Resnik, Barry I and Rosmarin, David and Roth, Gretchen M and Sayed, Christopher J and Silva, Dimitri Luz Felipe and Thorlacius, Linnea and Tzellos, Thrasyvoulos and van der Zee, Hessel and van Straalen, Kelsey and Ingram, John R},
title = {Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa},
journal = {JAMA Dermatology},
year = {2026},
doi = {10.1001/jamadermatol.2025.4652}
}
EUVIMED